ストックスクリーナーアプリを入手
12.75
13.26%
-1.9499
プレマーケット:
14.50
1.7499
+13.72%
前日終値:
$14.70
開ける：
$15.06
24時間の取引高:
22,375
Relative Volume:
6.13
時価総額：
$43.81M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-56.28%
1か月 パフォーマンス:
-69.80%
6か月 パフォーマンス:
-75.18%
1年 パフォーマンス:
-68.68%
1日の値動き範囲:
$12.00
$15.75
1週間の範囲:
$8.20
$17.50
52週間の値動き範囲:
$8.20
$17.50
Eloxx Pharmaceuticals Inc Stock (ELOX) Company Profile
Compare ELOX vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELOX
Eloxx Pharmaceuticals Inc
|
12.75 | 50.51M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
453.17 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.73 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
878.49 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
281.90 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.58 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Eloxx Pharmaceuticals Inc Stock (ELOX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-12-17 | 開始されました | Oppenheimer | Outperform |
| 2021-06-30 | 開始されました | Mizuho | Buy |
| 2021-05-27 | 開始されました | B. Riley Securities | Buy |
| 2020-06-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2019-09-06 | 開始されました | Janney | Buy |
| 2018-12-24 | 開始されました | H.C. Wainwright | Neutral |
| 2018-07-03 | 開始されました | Citigroup | Buy |
すべてを表示
Eloxx Pharmaceuticals Inc (ELOX) 最新ニュース
Invus-led group holds 9.99% of Eloxx (ELOX) via shares and warrants - Stock Titan
ELOX Technical Analysis & ETF Price Forecast - Intellectia AI
symbol__ Stock Quote Price and Forecast - CNN
ELOX Price Today: Eloxx Pharmaceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Eloxx Pharma (ELOX) Stock Analysis Report | Financials & Insights - Benzinga
Eloxx (NASDAQ: ELOX) CEO receives 328,833 performance-based stock options - Stock Titan
Eloxx Pharmaceuticals (ELOX) director receives 13,587 stock options grant - Stock Titan
Eloxx (ELOX) director Steven Rubin receives 4,018 stock options at $11 strike - Stock Titan
Eloxx (ELOX) director Stephen Webster receives stock options for 13,587 shares - Stock Titan
ELOX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
ELOX Technical Analysis & Stock Price Forecast - Intellectia AI
ELOX PE Ratio & Valuation, Is ELOX Overvalued - Intellectia AI
ELOX News & Events - Intellectia AI
ELOX Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
Eloxx Pharmaceuticals, Inc.(NasdaqCM: ELOX) added to NASDAQ Composite Index - marketscreener.com
Form 424B4 Eloxx Pharmaceuticals, - StreetInsider
Eloxx Pharmaceuticals (ELOX) raises ~$66M via stock and pre‑funded warrants - Stock Titan
Eloxx Pharmaceuticals Offering Expected to Close June 10 >ELOX - Moomoo
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering - Pharmaceutical Executive
[EFFECT] Eloxx Pharmaceuticals, Inc. SEC Filing - Stock Titan
Eloxx Pharmaceuticals prices $66.0 million offering, uplists to Nasdaq - scanx.trade
Eloxx Pharmaceuticals: Shares Expected to Start Trading on Nasdaq Capital Market on June 9 >ELOX - Moomoo
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq - PR Newswire
Eloxx Pharmaceuticals Inc (ELOXD) Stock PDF (Updated: 2026/06/06) - GuruFocus
ELOX SEC FilingsEloxx Pharmaceut 10-K, 10-Q, 8-K Forms - Stock Titan
Domicilium files Schedule 13G/A reporting 4.9% stake in Eloxx (NASDAQ: ELOX) - Stock Titan
Domicilium Real Estate Fund III LP (ELOX) swaps 1.25M shares for pre-funded warrants - Stock Titan
Total debt per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Working capital per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Book value per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Return on invested capital % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
EBITDA per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Free cash flow per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Debt to equity ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Net current asset value per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Asset turnover of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Operating cash flow per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Long term debt to total assets ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
CapEx per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Long term debt to total equity ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Debt to assets ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Return on assets % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Price to cash flow ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
EBIT per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Enterprise value of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Eloxx Pharmaceuticals, Inc. Statistics – OTC:ELOXD - TradingView
Enterprise value to EBITDA ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
EBITDA margin % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Total liabilities of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Net margin % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Total debt of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Eloxx Pharmaceuticals Inc (ELOX) 財務データ
Eloxx Pharmaceuticals Inc (ELOX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.27%
1.43%
大文字化:
|
ボリューム (24 時間):